Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance

PloS One
Sung Hyun AhnKyun-Hwan Kim

Abstract

The emergence of compensatory mutations in the polymerase gene of drug resistant hepatitis B virus (HBV) is associated with treatment failure. We previously identified a multi-drug resistant HBV mutant, which displayed resistance towards lamivudine (LMV), clevudine (CLV), and entecavir (ETV), along with a strong replication capacity. The aim of this study was to identify the previously unknown compensatory mutations, and to determine the clinical relevance of this mutation during antiviral therapy. In vitro mutagenesis, drug susceptibility assay, and molecular modeling studies were performed. The rtL269I substitution conferred 2- to 7-fold higher replication capacity in the wild-type (WT) or YMDD mutation backbone, regardless of drug treatment. The rtL269I substitution alone did not confer resistance to LMV, ETV, adefovir (ADV), or tenofovir (TDF). However, upon combination with YMDD mutation, the replication capacity under LMV or ETV treatment was enhanced by several folds. Molecular modeling studies suggested that the rtL269I substitution affects template binding, which may eventually lead to the enhanced activity of rtI269-HBV polymerase in both WT virus and YMDD mutant. The clinical relevance of the rtL269I substitution was...Continue Reading

References

Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M MelegariJ R Wands
Feb 28, 2003·The New England Journal of Medicine·Patrick MarcellinUNKNOWN Adefovir Dipivoxil 437 Study Group
Dec 21, 2005·Journal of Hepatology·Stephen Locarnini, William S Mason
Mar 10, 2006·The New England Journal of Medicine·Ting-Tsung ChangUNKNOWN BEHoLD AI463022 Study Group
Feb 3, 2007·Journal of Virology·David R LangleyDaniel J Tenney
Mar 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jay H HoofnagleAnna S F Lok
Apr 6, 2007·Gastroenterology·Marc Ghany, T Jake Liang
Sep 10, 2009·Gastroenterology·Fabien Zoulim, Stephen Locarnini
Aug 31, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kyun-Hwan KimBaik-Lin Seong
Oct 18, 2011·The Journal of Antimicrobial Chemotherapy·Chih-Lang LinChau-Ting Yeh
Mar 9, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Dong JiDongping Xu
Mar 1, 2010·Expert Opinion on Drug Discovery·Kyun-Hwan KimBaik-Lin Seong
Aug 16, 2012·Clinical and Molecular Hepatology·UNKNOWN Korean Association for the Study of the Liver
Oct 18, 2013·Clinical and Molecular Hepatology·Hyung Joon Yim, Seong Gyu Hwang
Jun 11, 2014·World Journal of Gastroenterology : WJG·Jeong Han KimKyun-Hwan Kim
Apr 8, 2015·World Journal of Hepatology·Yoshihiko YanoYoshitake Hayashi

❮ Previous
Next ❯

Citations

Feb 7, 2018·Hepatology Communications·Norie YamadaTakanobu Kato

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
ELISA
genotyping
different
glycosylation

Software Mentioned

Multi
Maestro
Gauge
OPLS
Linux

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.